메뉴 건너뛰기
American Journal of Epidemiology
Volumn 177, Issue 8, 2013, Pages 864-865
Re: "Clinical usefulness of the framingham cardiovascular risk profile beyond its statistical performance: The tehran lipid and glucose study"
Author keywords

[No Author keywords available]
Indexed keywords

GLUCOSE; LIPID;
EID: 84876249616     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt043     Document Type: Letter
Times cited : (3)
References (8)
  • 1
    • 84864449934 scopus 로고    scopus 로고
    • Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: The Tehran Lipid and Glucose Study
    • Khalili D, Hadaegh F, Soori H, et al. Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance:the Tehran Lipid and Glucose Study. Am J Epidemiol. 2012;176(3):177-186.
    • (2012) Am J Epidemiol. , vol.176 , Issue.3 , pp. 177-186
    • Khalili, D.1    Hadaegh, F.2    Soori, H.3
  • 2
    • 33750905259 scopus 로고    scopus 로고
    • Decision curve analysis: A novel method for evaluating prediction models
    • Vickers AJ, Elkin EB. Decision curve analysis:a novel method for evaluating prediction models. Med Decis Making. 2006; 26(6):565-574.
    • (2006) Med Decis Making. , vol.26 , Issue.6 , pp. 565-574
    • Vickers, A.J.1    Elkin, E.B.2
  • 3
    • 58149269742 scopus 로고    scopus 로고
    • Extensions to decision curve analysis, a novel method forevaluating diagnostic tests, prediction models and molecular markers
    • Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method forevaluating diagnostic tests, prediction models and molecular markers. BMCMed Inform Decis Mak. 2008;8:53.
    • (2008) BMCMed Inform Decis Mak. , vol.8 , pp. 53
    • Vickers, A.J.1    Cronin, A.M.2    Elkin, E.B.3
  • 4
    • 72949090243 scopus 로고    scopus 로고
    • Putting risk prediction in perspective:relative utility curves
    • Baker SG. Putting risk prediction in perspective:relative utility curves. JNatl Cancer Inst. 2009;101(22):1538-1542.
    • (2009) JNatl Cancer Inst. , vol.101 , Issue.22 , pp. 1538-1542
    • Baker, S.G.1
  • 5
    • 67650046515 scopus 로고    scopus 로고
    • Using relative utility curves to evaluate risk prediction
    • Baker SG, Cook NR, Vickers A, et al. Using relative utility curves to evaluate risk prediction. J R Stat Soc Ser A Stat Soc. 2009;172(4):729-748.
    • (2009) J R Stat Soc ser A Stat Soc. , vol.172 , Issue.4 , pp. 729-748
    • Baker, S.G.1    Cook, N.R.2    Vickers, A.3
  • 6
    • 0016757157 scopus 로고
    • Therapeutic decision making:acost-benefit analysis
    • Pauker SG, Kassirer JP. Therapeutic decision making:acost-benefit analysis. N Engl J Med. 1975;293(5):229-234.
    • (1975) N Engl J Med. , vol.293 , Issue.5 , pp. 229-234
    • Pauker, S.G.1    Kassirer, J.P.2
  • 7
    • 84876453962 scopus 로고    scopus 로고
    • University Of Washington Biostatistics Working Paper Series, working paper 384). Berkeley, CA:bepress Accessed December 23, 2012
    • Pepe MS, Janes H. Methodsfor Evaluating Prediction Performance of Biomarkers and Tests. (University of Washington Biostatistics Working Paper Series, working paper 384). Berkeley, CA:bepress; 2012. (http://biostats. bepress.com/ uwbiostat/paper384). (Accessed December23, 2012).
    • (2012) Methodsfor Evaluating Prediction Performance of Biomarkers and Tests
    • Pepe, M.S.1    Janes, H.2
  • 8
    • 84864458749 scopus 로고    scopus 로고
    • Invited commentary:clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance
    • D'Agostino RB, Pencina MJ. Invited commentary:clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance. Am J Epidemiol. 2012; 176(3):187-189.
    • (2012) Am J Epidemiol. , vol.176 , Issue.3 , pp. 187-189
    • D'Agostino, R.B.1    Pencina, M.J.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.